Hemodynamic effects of medetomidine in the dog: a dose titration study.

OBJECTIVE To characterize the hemodynamic effects of medetomidine administered intravenously at doses ranging from 1 to 20 microg/kg, and to determine whether these effects are dose dependent. STUDY DESIGN Prospective randomized multidose trial. ANIMALS Twenty-five clinically normal male beagles (5 groups of 5), aged 1 to 4 years and weighing 13.5 +/- 1.7 kg. METHODS Medetomidine, at a dose of 1, 2, 5, 10, or 20 microg/kg, was administered intravenously at time 0. Heart rate, arterial pressure, central venous pressure, mean pulmonary arterial pressure, pulmonary capillary wedge pressure, body temperature, cardiac output, and packed cell volume were measured immediately before and at selected times after medetomidine administration (3, 7, 10, 20, 30, 40, 50, and 60 minutes in all groups, at 90 minutes for the 10 and 20 microg/kg groups, and at 120 minutes for the highest dose). Cardiac index, stroke index, rate-pressure product, systemic vascular resistance index, pulmonary vascular resistance index, and left and right ventricular stroke work indices were calculated. The degree of sedation was subjectively scored by an observer who was blinded to the treatment used. RESULTS Heart rate, rate-pressure product, cardiac index, and left and right ventricular stroke work indices decreased below baseline values. Central venous pressure and systemic vascular resistance index increased above baseline measurements. Except in the 2 microg/kg group, after an initial and short lasting increase, a prolonged decrease in arterial pressure was observed. CONCLUSIONS Hemodynamic changes were observed with the intravenous (IV) administration of medetomidine, at any dose. However, the two lowest doses (1 and 2 microg/kg) produced less cardiovascular depression. CLINICAL RELEVANCE Medetomidine is an alpha-2 adrenoceptor agonist widely used in dogs, producing sedation, analgesia and cardiovascular depression. When using IV medetomidine, a reduction of the recommended dosage (ie, +/-30 to 40 microg/kg) by up to 6 times did not significantly influence the cardiovascular effects.

[1]  P. Talke,et al.  Effects of Perioperative Dexmedetomidine Infusion in Patients Undergoing Vascular Surgery , 1995, Anesthesiology.

[2]  A. Lehtinen,et al.  The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. , 1991, Anesthesiology.

[3]  M. Maze,et al.  Alpha‐2 Adrenoceptor Agonists: Defining the Role in Clinical Anesthesia , 1991, Anesthesiology.

[4]  S. Haskins,et al.  Xylazine and xylazine-ketamine in dogs. , 1986, American journal of veterinary research.

[5]  M. Zornow.  Ventilatory, hemodynamic and sedative effects of the α 2 adrenergic agonist, dexmedetomidine , 1991, Neuropharmacology.

[6]  O. Vainio.  Introduction to the clinical pharmacology of medetomidine. , 1989, Acta veterinaria Scandinavica. Supplementum.

[7]  M. Scheinin,et al.  Intramuscular dexmedetomidine, a novel alpha2‐ adrenoceptor agonist, as premedication for minor gynaecological surgery , 1991, Acta anaesthesiologica Scandinavica.

[8]  Muir Ww,et al.  Effect of xylazine on indices of myocardial contractility in the dog. , 1977 .

[9]  M. Maze,et al.  Anesthetic and Hemodynamic Effects of the Stereoisomers of Medetomidine, an α2‐Adrenergic Agonist, in Halothane‐Anesthetized Dogs , 1988, Anesthesia and analgesia.

[10]  L. Young,et al.  Effects of combinations of medetomidine/pethidine when used for sedation and pre‐anaesthetic medication in dogs , 1993 .

[11]  K. Am,et al.  Cardiopulmonary effects of xylazine in dogs. , 1975 .

[12]  B. C. Bloor,et al.  Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog. , 1993, Journal of cardiothoracic and vascular anesthesia.

[13]  J. Kampine,et al.  The effects of the stereoisomers of the alpha 2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. , 1991, Anesthesiology.

[14]  H. Alibhai,et al.  Cardiopulmonary effects of combinations of medetomidine hydrochloride and atropine sulphate in dogs , 1996, Veterinary Record.

[15]  J. Verstegen,et al.  Medetomidine-butorphanol-midazolam for anaesthesia in dogs and its reversal by atipamezole , 1993, Veterinary Record.

[16]  M. Lamy,et al.  Circulatory and respiratory effects of the combination medetomidine-ketamine in beagles. , 1993, Journal of veterinary pharmacology and therapeutics.

[17]  F. Szlam,et al.  Anesthetic and Hemodynamic Interactions of Dexmedetomidine and Fentanyl in Dogs , 1991, Anesthesiology.

[18]  W. Olson,et al.  Hemodynamic effects of intravenous midazolam-xylazine-butorphanol in dogs. , 1990, Veterinary surgery : VS.

[19]  D. Bartram,et al.  Use of medetomidine and butorphanol for sedation in dogs , 1994 .

[20]  B. C. Bloor,et al.  Hemodynamic and sedative effects of dexmedetomidine in dog. , 1992, The Journal of pharmacology and experimental therapeutics.

[21]  J. Thurmon,et al.  Cardiopulmonary effects of an intravenous infusion of guaifenesin, ketamine, and xylazine in dogs. , 1985, American journal of veterinary research.

[22]  B. Pypendop,et al.  A comparison of the sedative and analgesic effects of buprenorphine in combination with acepromazine, midazolam or medetomidine in dogs , 1994 .

[23]  B. Bloor,et al.  Hemodynamic Effects of Dexmedetomidine, an α2-Adrenergic Agonist, in Autonomically Denervated Dogs , 1990, Journal of cardiovascular pharmacology.

[24]  M. Scheinin,et al.  Alpha2‐adrenergic agents in anaesthesia , 1993, Acta anaesthesiologica Scandinavica.

[25]  K. Korttila,et al.  Comparison of Intramuscular Dexmedetomidine and Midazolam Premedication for Elective Abdominal Hysterectomy , 1994, Anesthesia and analgesia.

[26]  D. Serteyn,et al.  Hemodynamic effects of medetomidine-midazolam-butorphanol and medetomidine-midazolam-buprenorphine combinations and reversibility by atipamezole in dogs. , 1996, American journal of veterinary research.

[27]  R. Virtanen.  Pharmacological profiles of medetomidine and its antagonist, atipamezole. , 1989, Acta veterinaria Scandinavica. Supplementum.

[28]  J. W. Hall,et al.  Veterinary anaesthesia.. ed. 9 , 1991 .